RamaZottius Lab is a Lithuanian medtech start-up founded by women scientists and entrepreneurs with a clear mission: to transform the treatment of periodontal disease through safer, more effective, and non-invasive solutions.
A Breakthrough in Gum Health
The company’s flagship innovation, Periozip® gel, offers a non-invasive alternative to surgical treatments for periodontal disease. Recognised as one of the safest options currently available, Periozip helps protect gums, prevent tooth loss, and safeguard dental implants, significantly improving patient outcomes without the need for surgery.
Since 2020, RamaZottius Lab has combined pharmaceutical biotechnology expertise with strong business know-how, developing clinically validated solutions supported by health innovation programmes.
Through its participation in the atTRACTION and EuroQuity community, RamaZottius Lab aims to:
-
Connect with investors and strategic business partners across Europe
-
Showcase Periozip within a curated deep-tech ecosystem
-
Participate in investor pitch sessions and expand international collaborations
Drawing from their entrepreneurial journey, the team at RamaZottius Lab shares key advice for emerging founders:
-
Address a real clinical or market need with a differentiated solution
-
Build a multidisciplinary team to strengthen resilience
-
Engage early with international networks and continuously refine the product based on feedback
What’s Next
The next milestones for RamaZottius Lab include:
-
Securing CE certification for Periozip as a Class IIa medical device
-
Scaling commercialisation through licensing strategies
-
Building strategic partnerships to support global market entry
With a strong foundation in science, collaboration, and innovation, RamaZottius Lab is actively shaping the future of gum health and periodontal care.
🔗 Learn more:
https://lnkd.in/eePXzfhv
